Director, HEOR

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Summary

The purpose of this job is to develop HEOR strategies for the assigned products and implement scientifically rigorous HEOR activities aligning with the global R&D, commercial and market access strategies, contributing to optimal pricing, reimbursement and market access in the US.

Responsibilities

• Provision of HEOR strategic direction to project teams
  Provide HEOR strategic direction to cross-functional teams and provide recommendations on such aspects as appropriate comparators, target patient populations, clinical and economic end-points and patient-reported outcomes (PROs), ensuring the US healthcare stakeholder perspective is incorporated in the assigned clinical development programs and the evidence needed to support optimal market access is addressed. Contribute HEOR sections to target product profiles (TPPs), product development plans, clinical development plans, and commercialization plans and other critical documents.
  • Level: Contribute to multiple Ph1-2b or single Ph3 GPTs and GBTs independently and with consultation if needed.
• Development of value propositions and implementing HEOR studies
  Lead the development of value propositions that differentiate DS products for US health policy decision-makers, government & commercial payers, consumers and other stakeholders. Identify the supporting evidence requirements in alignment with the GPTs, GBTs, Medical Affairs and Market Access functions.
  Plan and conduct HEOR studies such as early economic models, observational studies, the development and validation of patient-reported outcome (PRO) instruments and others. Lead the preparation of value dossiers or similar documents which present the product value propositions and the supporting evidence to realize an optimal value demonstration of DS products.
  • Level: Develop value propositions, identify evidence requirements and plan and execute HEOR studies independently, and with consultation if needed.
• HEOR scientific publications & communications
  Develop HEOR communication materials (e.g. manuscripts, scientific forum presentations, slide kits, symposia) in collaboration with multi-functional teams to build the peer reviewed published evidence supporting the value propositions for DS products.
  • Level: Develop independently and with consultation if needed.
• Vendor management
  Effectively manage the entire process for projects outsourced to external consultancies and contractors, ensuring delivery according to key milestones, budget and expected quality.
  • Level: Manage
• Internal Collaboration
  Collaborate and communicate effectively with internal global/ regional functional peers and cross functional colleagues/ teams, share knowledge and provide input on US HEOR needs, to enhance effective functioning of the DS matrix structure as well as contributing to meet global and US program objectives.
  • Level: Contribute to matrix teams independently and with consultation if needed.
• External Collaboration
  Lead and/or contribute to Daiichi Sankyo meetings with external bodies such as regulatory and health technology assessment agencies to seek external input on HEOR evidence generation strategies and plans for assigned products.
  Effectively represent Daiichi Sankyo at major external agency meetings, public health policy and reimbursement discussion forums with decision makers from these constituencies and partner with key opinion leaders (KOLs), ensuring the desired positioning of DS is articulated and taken into account.
  • Level: Contribute to meetings with external regulatory and HTA bodies independently and with consultation if needed.
• Knowledge of HEOR scientific methods and health policy environment
  Maintain and continue to enhance knowledge about HEOR methods and the evolving US health policy and reimbursement environment.

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education Qualifications (from an accredited college or university)

• Master's Degree in a relevant discipline (e.g., health economics, health services research, medicine, pharmacy, public health, psychometrics, epidemiology, and decision sciences) required
• PhD in a relevant discipline (e.g., health economics, health services research, medicine, pharmacy, public health, psychometrics, epidemiology, and decision sciences) preferred

Experience Qualifications

• 10 or More Years experience in the healthcare or pharmaceutical industry, or commensurate education/experience, 8 of which must be working in the health economics and outcomes research field required
• Hands on experience with HEOR methodologies across all phases of the product life cycle required
• Keen insight and track record of successful application of HEOR data with key external stakeholders in US markets preferred
• Knowledge of Oncology preferred

TravelAbility to travel up to 30%

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.